The PIONEER 5 study was a multicenter, double-blind, randomized, placebo-controlled, phase 3a trial where 324 participants, age 18yrs, with type 2 diabetes, HbA1C 7.0-9.0% and moderate renal impairment (eGFR 30-59 mL/min/1.732), were randomly assigned to receive either once-daily oral semaglutide on an empty stomach with up to half a glass of water and 30min before any food/beverage/medication, or placebo for 26 weeks with a follow up period of 5 weeks, with their standard glucose-lowering medication
Results A total of 648,070 adult patients with T2D and NAFLD were identified, and patients were categorized into three different comparison groups based on their drug of interest
Visit our Research Page to follow updates and see the published outcomes once available
(Tip): Add a serving to sparkling water for a delicious anytime drink
Photo Credit: Jessica Kielman, Baldwin Publishing 120 mins Simple, flavorful, and versatile, this roasted chicken is a reliable source of protein thats easy to make and feeds the whole family
(b) uncontrolled hypertension, which is a systolic blood pressure above 140 mm Hg or diastolic blood pressure above 90 mm Hg while on two antihypertensive medications